References
- de Winter DP, Kaminski A, Tjoa ML, Oepkes D. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape. BMC Pregnancy Childbirth 2023;23:12.
- Lopez GH, Hyland CA, Flower RL. Glycophorins and the MNS blood group system: a narrative review. Ann Blood 2021;6:Art 6479.
- Tormey CA, Hendrickson JE. Transfusion-related red blood cell alloantibodies: induction and consequences. Blood 2019;133:1821–30.
- Hendrickson JE, Delaney M. Hemolytic disease of the fetus and newborn: modern practice and future investigations. Transfus Med Rev 2016;30:159–64.
- Rattakul A, Intharanut K, Nathalang O. The prevalence of red cell antibodies among patients and pregnant women in Pakchongnana Hospital. Arch Adv Biosci 2019;10:30–6. https://doi.org/10.22037/aab.v10i3.26156. Accessed 29 September 2024.
- Senavirathna S, Ranasinghe L, Thilakarathne Y. Estimation of prevalence of red cell alloantibodies in patients with beta thalassaemia major in Sri Lanka. Ceylon Med J 2021;66.
- Getshen M, Yangdon T, Tashi L, Dorji D. Prevalence of “unexpected antibodies” in patients requiring blood transfusion at National Referral Hospital, Thimphu from 2015 to 2017: retrospective study. JMSCR 2019;7:320–3.
- Nadarajan VS, Laing AA, Saad SM, Usin M. Prevalence and specificity of red–blood–cell antibodies in a multiethnic South and East Asian patient population and influence of using novel MUT+ Mur+ kodecytes on its detection. Vox Sang 2012;102:65–71.
- Waggiallah HA, Alenzi FQ, Shaya ASB, Hattan AH, Elmosaad YM, Alenazi MM. The prevalence of unexpected antibodies in Saudi’s plasma prior blood transfusion and their association with clinical conditions: a cross-sectional study. Saudi J Biol Sci 2021;28:4699–703.
- British Committee for Standards in Haematology. Guidelines for pre-transf usion compatibilit y procedures in blood transfusion laboratories. Transfus Med 2013;23:3–35.
- Hassan MN, Noor NHM, Noor SRJ, Sukri SA, Mustafa R, Aster HVRL. Hemolytic disease of fetus and newborn due to maternal red blood cell alloantibodies in the Malay population. Asian J Transfus Sci 2014;8:113–7.
- National Blood Transfusion Service. National haemovigillance report. Sri Lanka: National Blood Transfusion Service, 2017.
- Smith HM, Shirey RS, Thoman SK, Jackson JB. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility. Immunohematology 2013;29:127–30.
- Sahoo BB, Mishra MS, Mishra D, Panigrahy R, Parida P. Prevalence of red cell alloantibodies in pregnant women. Haematology Int J 2020;4:1–9.
- Harmening DM. Modern Blood Banking & Transfusion Practices. 7th ed. Philadelphia: F.A. Davis Company; 2018
- Liumbruno GM, D’Alessandro A, Rea F, et al. The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh (D) alloimmunisation. Blood Transfus 2010;8:8.
- Basu S, Kaur R, Kaur G. Hemolytic disease of the fetus and newborn: current trends and perspectives. Asian J Transfus Sci 2011;5:3–7.
- Das S, Shastry S, Rai L, Baliga PB. Frequency and clinical significance of red cell antibodies in pregnancy: a prospective study from India. Indian J Pathol Microbiol 2020;63:241–6.
- Awowole I, Cohen K, Rock J, Sparey C. Prevalence and obstetric outcome of women with red cell antibodies in pregnancy at the Leeds Teaching Hospitals NHS Trust, West Yorkshire, England. Eur J Obstet Gynecol Reprod Biol 2019;23:89–92.
- Delaney M, Matthews DC. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn. Hematology Am Soc Hematol Educ Program 2015;2015:146–51.
- White J, Qureshi H, Massey E, et al. Guideline for blood grouping and red cell antibody testing in pregnancy. Transfus Med 2016;26:246–63.
- Gothwal M, Singh P, Bajpayee A, Agrawal N, Yadav G, Sharma C. Red cell alloimmunization in pregnancy: a study from a premier tertiary care centre of Western India. Obstet Gynecol Sci 2023;66:84–93.